News Column

PDL BIOPHARMA, INC. FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

January 30, 2014

Item 8.01 Other Events. PDL BioPharma Announces Continuing Operations On January 29, 2014 , the board of directors of PDL BioPharma, Inc. (the Company) made the strategic decision to continue its operations post expiration of the Queen et al. patents and to continue the strategy of pursuing new income generating assets so as to extend its ability to pay dividends to its shareholders. On January 30, 2014 , the Company issued a press release announcing the decision to continue operations. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. PDL BioPharma Announces 2014 Quarterly Dividends On January 29, 2014 , the Company's board of directors declared that the regular, quarterly dividends to be paid to its stockholders in 2014 will be $0.15 per share of common stock. The $0.15 dividends will be paid on March 12 , June 12 , September 12 and December 12 of 2014 to all stockholders who own shares of the Company on March 5 , June 5 , September 5 and December 5 of 2014, the record dates for each of the dividend payments, respectively. On January 30, 2014 , the Company issued a press release announcing the 2014 dividends. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Cautionary Statements This filing and the press release include "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or predictions of future conditions, events or results based on various assumptions and management's estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", "projects", "forecasts", "may", "should", variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding product development, product potential or financial performance. As all dividend payments are subject to compliance with legal requirements, dividend announcements constitute "forward-looking statements" and could be withdrawn prior to payment at the discretion of the Company's board of directors. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect the business of PDL and its markets, particularly those discussed in the risk factors and cautionary statements contained in the Company's 2012 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 1, 2013 , as updated by subsequent periodic reports. All forward-looking statements are expressly qualified in their entirety by such factors. The forward-looking statements are representative only as of the date they are made, and PDL assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise. -------------------------------------------------------------------------------- Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release --------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools